Clinical Trial: A prospective, multicenter clinical study on the diagnosis of AD-related blood biomarkers in China and the evaluation of the efficacy of lencanimab (China)

Posted On: 2026-09-14

China, Sept. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter clinical study on the diagnosis of AD-related blood biomarkers in China and the evaluation of the efficacy of lencanimab'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132316

Registration Time: 2026/09/11

Type: Interventional study

Primary Sponsor: Tianjin Huanhu Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339521

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, multicenter clinical study on the diagnosis of AD-related blood biomarkers in China and the evaluation of the efficacy of lencanimab (China)